HCID 22240278, compound → HCID 69563679, compound

HRID 891922Notes

Reaction equation

HRID 891922 reaction equation
[F:1][CH:2]([F:19])[C:3]1[CH:4]=[C:5](B2OC(C)(C)C(C)(C)O2)[CH:6]=[CH:7][C:8]=1[F:9].[Cl:20][C:21]1[CH:22]=[C:23]([CH2:27][CH2:28][N:29]2[CH:33]=[CH:32][N:31]=[C:30]2[CH2:34][CH3:35])[N:24]=[N:25][CH:26]=1>>[ClH:20].[F:19][CH:2]([F:1])[C:3]1[CH:4]=[C:5]([C:21]2[CH:22]=[C:23]([CH2:27][CH2:28][N:29]3[CH:33]=[CH:32][N:31]=[C:30]3[CH2:34][CH3:35])[N:24]=[N:25][CH:26]=2)[CH:6]=[CH:7][C:8]=1[F:9]

Participants

3

Procedure

The title compound, MS: m/e=333.3 (M+H+), was prepared from 2-(3-difluoromethyl-4-fluoro-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane and 5-chloro-3-(2-ethyl-imidazol-1-ylethyl)-pyridazine.

Sources & evidence

ORD record
ord-063b7d5dcdbf41ddb706b6f1cd26172a
Source dataset
uspto-grants-2006_02
Patent number
US07005432B2

Reaction notes

Loading…